Xeris gets EC approval for Ogluo to treat hypoglycaemia in diabetics
Xeris Pharmaceuticals has secured the European Commission (EC) approval for Ogluo (glucagon) injection to treat severe hypoglycaemia in people aged two years and older, with diabetes mellitus. The